4.87
+0.0699(+1.46%)
Currency In USD
| Previous Close | 4.8 |
| Open | 4.76 |
| Day High | 5.07 |
| Day Low | 4.76 |
| 52-Week High | 29.28 |
| 52-Week Low | 1.62 |
| Volume | 28,294 |
| Average Volume | 65,273 |
| Market Cap | 9.31M |
| PE | -0.25 |
| EPS | -19.29 |
| Moving Average 50 Days | 4.97 |
| Moving Average 200 Days | 4.95 |
| Change | 0.07 |
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
GlobeNewswire Inc.
Jun 03, 2025 1:15 PM GMT
ATLANTA, June 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announced that
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
GlobeNewswire Inc.
May 08, 2025 1:00 PM GMT
- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Study - - Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b study interim data readout is expected in Q4 2025 - - Cash
Dogwood Therapeutics, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference
Newsfile
May 01, 2025 12:30 PM GMT
Alpharetta, Georgia--(Newsfile Corp. - May 1, 2025) - Dogwood Therapeutics, Inc. (NASDAQ: DWTX), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.Gre